Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted May 31, 2014
Sellers of "Cancer" Supplements Warned for Drug Claims
Two sellers of graviola supplements promoted to treat cancer have been issued warning letters by the FDA.
Graviola (Annona muricata), also known as soursop, is the fruit of a tree native to South America and Puerto Rico.
On March 28, 2014, the FDA issued a warning letter to M&A Caribbean Traders, Inc., following a review of the company's website which found statements made about the supplement MegaGraviola be drug claims.
MegaGraviola was promoted with statements such as "Scientists... discovered its ability to kill malignant cells of 12 different types of cancer, including ovarian, colon, breast, prostate, lung, liver, cervical, lymphoma, and pancreatic cancer. Laboratory research showed it to be 10,000 times stronger in killing colon cancer cells than Adriamycin, a commonly used drug. And Graviola, unlike chemotherapy, can kill cancer cells without harming healthy cells."
On April 2, 2014, the FDA also issued a warning letter to Graviola Group, following a review of the company's website which found statements made about the supplement Graviola Extract be drug claims.
Graviola Extract was promoted to treat cancer with statements such as "graviola extract is the best alternative supplement to support the cancer tratments [sic] and to help with the cure of the following types of cancer: Prostate cancer, (Also help with the Prostatitis) Breast cancer Lung cancer Colon cancer, (Rectume [sic] Cancer) Uterus Cancer Non-Hodgkin Melanoma Skin cancer Kidney Cancer Ovary Cancer."
See Related Warnings:
For more warnings and recalls, use the link below.